Shoosmiths support Five Arrows investment into Schivo Medical
November, 2024 - Milton Keynes, England
Law firm Shoosmiths has advised Five Arrows, the alternative assets arm of Rothschild & Co, on its investment into Schivo Medical (Schivo) - a medtech contract development and manufacturing organisation specialising in high precision engineering for the robotic assisted surgery, minimally invasive surgery and life sciences sectors.
Schivo is headquartered in Waterford, Ireland and operates from four sites across Ireland, US and Canada. The business has grown more than fivefold since 2017, now employing over 500 people across the group. This transaction allows MML Growth Capital Partners Ireland to successfully exit their previous minority position in the company.
The Shoosmiths team was led by corporate partners Amit Nayyar and Holly Hirst, with support from senior associate Brodie Thomson.
Kunal Pandit, partner at Five Arrows, commented: “Schivo is an outstanding medical outsourced contract development and manufacturing business servicing leading customers in the sector, with significant opportunity to grow both organically and via acquisition. We were attracted by Schivo’s differentiated ability to manufacture complex micro-engineered components, the sizeable end markets that it serves and the ability of the management team to execute on an ambitious growth plan. We are very pleased at the opportunity to invest in the company and look forward to working with Graham and the team to grow the business in the coming years – thank you once again to Shoosmiths for their expertise and support.”
Private Equity is one of Shoosmiths’ key markets and the team features in the top five most active UK law firms advising on private equity transactions, according to Pitchbook Global league tables 2023. This investment underscores the firm's dedication to advising some of the world’s most exciting and ambitious businesses.
